Human Papillomavirus Vaccination Trends, Barriers, and Promotion Methods Among American Indian/Alaska Native and Non-Hispanic White Adolescents in Michigan 2006–2015
- 43 Downloads
Human papillomavirus (HPV) infection, the most common sexually transmitted disease in the US, is a preventable cause of cancer. HPV vaccination has the potential to prevent 90% of HPV-related cancer cases but is underutilized, especially among American Indian/Alaska Native (AI/AN) adolescents. The objectives of this study were to (1) describe trends and identify predictors of HPV vaccination initiation and completion in Michigan’s AI and Non-Hispanic White children age 9 through 18 years and (2) to identify barriers to HPV vaccination and promotion methods at the tribal, state, and local levels in Michigan. Data from Michigan’s immunization information system from 2006 to 2015 were used for analysis. Additionally, semi-structured interviews were conducted with public health professionals across the state to identify barriers to and promoters of HPV vaccination. Predictors for vaccine initiation included being female, AI/AN, and living in high poverty zip code. Predictors of vaccine completion were female gender and younger age at vaccine initiation. Barriers to vaccination included misinformation and weak or inconsistent provider recommendations. Strategies used by health professionals to promote HPV vaccination included immunization summaries, vaccine information statements, the Vaccines for Children (VFC) program, and provider training. Findings suggested the need for education of parents to demystify HPV vaccine benefits and risks and provider training for more consistent recommendations.
KeywordsHuman papillomavirus American Indian Michigan Cervical cancer HPV vaccine Vaccine promotion
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Centers for Disease Control and Prevention, CDC. (2018a). HPV vaccine information for clinicians. Retrieved September 15, 2018, from https://www.cdc.gov/hpv/hcp/need-to-know.pdf.
- 2.Centers for Disease Control and Prevention, CDC. (2018b). Human papillomavirus (HPV): Questions and answers. Retrieved September 15, 2018, from https://www.cdc.gov/hpv/parents/questions-answers.html.
- 3.Centers for Disease Control and Prevention, CDC. (2018c). Human papillomavirus (HPV) vaccine safety. Retrieved September 15, 2018, from https://www.cdc.gov/vaccinesafety/vaccines/hpv-vaccine.html.
- 4.U.S. Food and Drug Administration, FDA. (2018). Human papillomavirus vaccine. Retrieved October 10, 2018, from https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm172678.htm.
- 5.Rimer, B., Harper, H., & Witte, O. (2014). Accelerating HPV vaccine uptake: Urgency for action to prevent cancer; a report to the President of the United States from the President’s Cancer Panel. Bethesda, MD: National Cancer Institute.Google Scholar
- 6.Reagan-Steiner, S., Yankey, D., Jeyarajah, J., et al. (2015). National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States. MMWR, 65(33), 850–858.Google Scholar
- 8.Centers for Disease Control and Prevention, CDC. (2018d). VFC detailed questions and answers for parents. Retrieved October 10, 2018, from https://www.cdc.gov/vaccines/programs/vfc/parents/qa-detailed.html.
- 9.Gable, J., Eder, J., Noonan, K., & Feemster, K. (2015). Increasing HPV vaccination rates among adolescents: Challenges and opportunities. Center to Bridge Research, Practice and Policy.Google Scholar
- 10.Centers for Disease Control and Prevention. (2017). AFIX (Assessment, Feedback, Incentives, and eXchange). Retrieved October 26, 2018, from https://www.cdc.gov/vaccines/programs/afix/index.html.
- 16.Bronheim, S., & Sockalingam, S. (2003). A guide to choosing and adapting culturally and linguistically competent health materials. National Center for Cultural Competence, Georgetown University Center for Child and Human Development.Google Scholar
- 17.Centers for Disease Control and Prevention, CDC. (2013). Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013—United States. MMWR, 62(29), 591–595.Google Scholar